# Clinical Trial Phase III to Assess the Non-inferiority of Dalap Duo® Product Compared to Epiduo® in the Treatment of Acne Vulgaris

> **NCT02716090** · PHASE3 · WITHDRAWN · sponsor: **Ache Laboratorios Farmaceuticos S.A.**

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Adapalene and Benzoyl peroxide Dalap Duo®
- **DRUG:** Adapalene and Benzoyl peroxide Epiduo®

## Key facts

- **NCT ID:** NCT02716090
- **Lead sponsor:** Ache Laboratorios Farmaceuticos S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2015-11
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Due to budget limitations, the company decided to withdraw this study.
- **Last updated:** 2017-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02716090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02716090, "Clinical Trial Phase III to Assess the Non-inferiority of Dalap Duo® Product Compared to Epiduo® in the Treatment of Acne Vulgaris". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02716090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*